Compound ID | 2844
Synonym(s): 2-aminopyrimidine robenidine analogue | 4,6-bis-[2-((E)−4-methylbenzylidene)hydrazinyl]pyrimidin-2-amine
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against Staphylococcus aureus, Streptococcus pneumoniae, vancomycin-resistant Enterococcus, and when in combination with colistin/polymyxin B to Escherichia coli, Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa |
| Description: | Synthetic compound based on the anticoccidial agent robenidine; shows synergistic effect with sub-inhibitory concentrations of colistin when used in MDR Gram-negative infection model; superior efficacy when administered via oral route than systemic route |
| Institute where first reported: | The University of Adelaide, Adelaide, South Australia, Australia |
| Year first mentioned: | 2017 |
| Development status: | Experimental |